NFE2L2 and Parkinson disease: In this study we take the first step towards evaluating the therapeutic potential of targeting NRF2 for cognitive enhancement in PD by exploring effects of modulating NRF2 activity on the physiological underpinnings of improved cognitive function, namely synaptic density.